CANY
SRPT icon

Caxton Associates (New York)’s Sarepta Therapeutics SRPT Stock Holding History

Caxton Associates (New York)’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,020
Closed -$484K – 490
2020
Q2 		$484K Buy
+3,020
New +$484K 0.04% 131